Literature DB >> 11260017

Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients.

Y Itoh1, Y Ninomiya, S Tajima, A Ishibashi.   

Abstract

BACKGROUND: Photodynamic therapy (PDT) is useful for treatment of epidermal neoplasia but may also have a role in the treatment of inflammatory dermatoses.
OBJECTIVES: To study the effect of PDT in patients with acne.
METHODS: Three men and 10 women who suffered from intractable acne vulgaris were treated using PDT with topical delta-aminolaevulinic acid (ALA) and polychromatic visible light. Twenty per cent ALA in an oil-in-water emulsion was applied to the lesions for 4 h with a light-shielding dressing. The lesions were then exposed to polychromatic visible light at 600-700 nm using a halogen light source of energy intensity 17 mW cm-2 and a total energy dose of 13 J cm-2.
RESULTS: All patients had apparent improvement of facial appearance and reduction of new acne lesions at 1, 3 and 6 months following PDT treatment. The adverse effects were discomfort, burning and stinging during irradiation, oedematous erythema for 3 days after PDT, epidermal exfoliation from the fourth to the 10th day, irritation and hypersensitivity to physical stimulation for 10 days after PDT, and pigmentation or erythema after epidermal exfoliation; the treated lesions returned to normal skin conditions within 1 month.
CONCLUSIONS: PDT was beneficial in the treatment of acne. As a photoactivating light source, polychromatic visible light was thought to be better for use with acne patients than laser light because of its cost-effectiveness, uniform illumination and time-efficiency in treating large areas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260017     DOI: 10.1046/j.1365-2133.2001.04086.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  21 in total

1.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

Review 2.  Photodynamic therapy targeted to pathogens.

Authors:  T N Demidova; M R Hamblin
Journal:  Int J Immunopathol Pharmacol       Date:  2004 Sep-Dec       Impact factor: 3.219

3.  Laser treatment of acne vulgaris.

Authors:  Ming H Jih; Arash Kimyai-Asadi
Journal:  Semin Plast Surg       Date:  2007-08       Impact factor: 2.314

4.  Therapeutic and Aesthetic Uses of Photodynamic Therapy Part two of a five-part series: Lasers and Light Treatments for Acne Vulgaris Promising Therapies.

Authors:  Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

5.  A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

Review 6.  [Light, laser and PDT therapy for acne].

Authors:  C Borelli; K Merk; G Plewig; K Degitz
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 7.  [Antibacterial photodynamic therapy. A new treatment for superficial bacterial infections?].

Authors:  T Maisch; R-M Szeimies; N Lehn; C Abels
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 8.  Photodynamic Therapy and Skin Appendage Disorders: A Review.

Authors:  Matteo Megna; Gabriella Fabbrocini; Claudio Marasca; Giuseppe Monfrecola
Journal:  Skin Appendage Disord       Date:  2016-12-08

9.  Topical ALA-Photodynamic Therapy for Acne Can Induce Apoptosis of Sebocytes and Down-regulate Their TLR-2 and TLR-4 Expression.

Authors:  Eugene Jeong; Ji Won Hong; Jung Ah Min; Dong Won Lee; Mi Yeung Sohn; Weon Ju Lee; Jun Young Lee; Young Min Park
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

Review 10.  Photodynamic therapy for infections: clinical applications.

Authors:  Gitika B Kharkwal; Sulbha K Sharma; Ying-Ying Huang; Tianhong Dai; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.